Latest in vitro diagnostics Stories

Rapidly expanding Asia-Pacific market is a focus area of every IVD company's long-term strategy MOUNTAIN VIEW, Calif., June 6, 2013 /PRNewswire/ -- Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry in some segments. Growth in emerging markets and next-wave emerging markets, particularly in the Asia-Pacific (APAC) region, are the most important factors in formulating future...

DUBLIN, June 6, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8hnfpv/in_vitro) has announced the addition of the "In Vitro Diagnostics - A Global Market Overview" [http://www.researchandmarkets.com/research/8hnfpv/in_vitro ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry...

“Point of Care Diagnostics Market: Products, Players and Outlook” is the new market research report at ReportsnReports.com store. Dallas, Texas (PRWEB) May 24, 2013 The point-of-care (POC) diagnostics market encompasses a wide range of products used outside the central laboratory, by other healthcare professionals, patient self-testers as supervised by a healthcare practitioner or by consumers. This includes products that test blood glucose levels, blood coagulation, fertility and...

This report presented by Research and Markets reviews, analyses and projects IVD market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. Dublin, Ireland (PRWEB) March 14, 2013 The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though some of these challenges...

DUBLIN, March 13, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3jd53x/the_top_100_distri) has announced the addition of the "The Top 100 Distributors of IVD Reagents, Instruments & Accessories in Europe" [http://www.researchandmarkets.com/research/3jd53x/the_top_100_distri ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) According to the latest estimates released by The...

CAMBRIDGE, Mass., March 8, 2013 /PRNewswire/ -- Endeavor Power Corporation ("Endeavor Power" or the "Company") (OTCQB: EDVP) introduces its proprietary FDA Cleared Target System Platform Immunoassay Testing Technology ("Target System"). Endeavor Sciences, Inc. ("Endeavor"), the Company's operating wholly owned subsidiarity is pleased to announce the introduction of the Target System, Endeavor's FDA Approved Immunoassay Testing Platform to target the Point-Of-Care Testing (POCT)...

GARDEN GROVE, Calif., Feb. 19, 2013 /PRNewswire/ -- HYCOR Biomedical, Inc. ("HYCOR"), a leading manufacturer and marketer of in vitro diagnostic products for the global allergy and autoimmune markets, today announced that it has sold its urinalysis business to an affiliate of One Rock Capital Partners, Laurel Crown Partners, and StoneCreek Capital. The sale includes the KOVA(®) system of urinalysis products. HYCOR is a portfolio company of Linden Capital Partners ("Linden"). "The...

ReportsnReports.com adds new research reports on “In Vitro Diagnostics market” that provide investment opportunities in Chile, Norway and United Arab Emirates. Dallas, Texas (PRWEB) January 12, 2013 These reports provide key market data on Chile, Norway and United Arab Emirates In Vitro Diagnostics market. These reports provide value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry,...

MOUNTAIN VIEW, Calif., Oct. 1, 2012 /PRNewswire/ -- Wako Life Sciences, Inc. is a newly incorporated company focused on the development, marketing, and sales of in vitro diagnostic products. As the former diagnostics division of Wako Chemicals USA, Wako Life Sciences will capitalize on its decades long reputation for high quality diagnostic reagents branded as Wako Diagnostic products. The new streamlined organization will accelerate the development of microfluidic test systems for...

CHILLY-MAZARIN, France, August 20, 2012 /PRNewswire/ -- InGen BioSciences, specialized in the development and commercialization of mono and multiparametric in vitro diagnostic tests announced exclusive partnerships with two key in vitro diagnostic companies, Quidel and Diagnostic Hybrids, for the distribution of their innovative tests on the French market. "These exclusive partnerships will allow InGen BioSciences to answer French biologists' unmet needs for early...